Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning

Abstract The impact of mitochondrial and lysosomal co-dysfunction on breast cancer patient outcomes is unclear. The objective of this study is to develop a predictive machine learning (ML) model utilizing mitochondrial and lysosomal co-regulators in order to provide a foundation for future studies f...

Full description

Saved in:
Bibliographic Details
Main Authors: Huilin Chen, Zhenghui Wang, Jiale Shi, Jinghui Peng
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86970-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571817133342720
author Huilin Chen
Zhenghui Wang
Jiale Shi
Jinghui Peng
author_facet Huilin Chen
Zhenghui Wang
Jiale Shi
Jinghui Peng
author_sort Huilin Chen
collection DOAJ
description Abstract The impact of mitochondrial and lysosomal co-dysfunction on breast cancer patient outcomes is unclear. The objective of this study is to develop a predictive machine learning (ML) model utilizing mitochondrial and lysosomal co-regulators in order to provide a foundation for future studies focused on breast cancer (BC) patients’ stratification and personalized interventions. Firstly, Differences and correlations of mitochondrial and lysosome related genes were screened and validated by differential analysis, copy number variation (CNV), single nucleotide polymorphism (SNPs) and correlation analysis. WGCNA and univariate Cox regression were employed to identify prognostic mitochondrial and lysosomal co-regulators. ML was utilized to further selected these regulators and then the coxboost + Survivor-SVM model was identified as the most suitable model for predicting outcomes in BC patients. Subsequently, the association between the immune and mlMSGs score was investigated through scRNA-seq. We found that the overall immunoinfiltration of immune cells was decreased in the high-risk group, it was specifically noted that B cell mlMSGs activity remained diminished in high-risk patients. Finally, the expression and function of the key gene SHMT2 were confirmed through in vitro experiments. This study shows that the ML model demonstrated a strong association with patient outcomes. Analysis conducted through the model has identified decreased B-cell immune infiltration and increased mlMSGs activity as significant factors influencing patient prognosis. These results may offer novel approaches for early intervention and prognostic forecasting in BC.
format Article
id doaj-art-b80d3cd59ccc498ba1e58f6139dc3ad8
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-b80d3cd59ccc498ba1e58f6139dc3ad82025-02-02T12:16:50ZengNature PortfolioScientific Reports2045-23222025-01-0115111910.1038/s41598-025-86970-4Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learningHuilin Chen0Zhenghui Wang1Jiale Shi2Jinghui Peng3Departments of Breast Surgery, First Affiliated Hospital, Nanjing Medical UniversityDepartments of Breast Surgery, First Affiliated Hospital, Nanjing Medical UniversityWomen and Children Central Laboratory, First Affiliated Hospital, Nanjing Medical UniversityDepartments of Breast Surgery, First Affiliated Hospital, Nanjing Medical UniversityAbstract The impact of mitochondrial and lysosomal co-dysfunction on breast cancer patient outcomes is unclear. The objective of this study is to develop a predictive machine learning (ML) model utilizing mitochondrial and lysosomal co-regulators in order to provide a foundation for future studies focused on breast cancer (BC) patients’ stratification and personalized interventions. Firstly, Differences and correlations of mitochondrial and lysosome related genes were screened and validated by differential analysis, copy number variation (CNV), single nucleotide polymorphism (SNPs) and correlation analysis. WGCNA and univariate Cox regression were employed to identify prognostic mitochondrial and lysosomal co-regulators. ML was utilized to further selected these regulators and then the coxboost + Survivor-SVM model was identified as the most suitable model for predicting outcomes in BC patients. Subsequently, the association between the immune and mlMSGs score was investigated through scRNA-seq. We found that the overall immunoinfiltration of immune cells was decreased in the high-risk group, it was specifically noted that B cell mlMSGs activity remained diminished in high-risk patients. Finally, the expression and function of the key gene SHMT2 were confirmed through in vitro experiments. This study shows that the ML model demonstrated a strong association with patient outcomes. Analysis conducted through the model has identified decreased B-cell immune infiltration and increased mlMSGs activity as significant factors influencing patient prognosis. These results may offer novel approaches for early intervention and prognostic forecasting in BC.https://doi.org/10.1038/s41598-025-86970-4Breast cancerMitochondrial and lysosomal dysfunctionMachine learningSc-RNAImmunotherapy
spellingShingle Huilin Chen
Zhenghui Wang
Jiale Shi
Jinghui Peng
Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning
Scientific Reports
Breast cancer
Mitochondrial and lysosomal dysfunction
Machine learning
Sc-RNA
Immunotherapy
title Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning
title_full Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning
title_fullStr Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning
title_full_unstemmed Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning
title_short Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning
title_sort integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning
topic Breast cancer
Mitochondrial and lysosomal dysfunction
Machine learning
Sc-RNA
Immunotherapy
url https://doi.org/10.1038/s41598-025-86970-4
work_keys_str_mv AT huilinchen integratingmitochondrialandlysosomalgeneanalysisforbreastcancerprognosisusingmachinelearning
AT zhenghuiwang integratingmitochondrialandlysosomalgeneanalysisforbreastcancerprognosisusingmachinelearning
AT jialeshi integratingmitochondrialandlysosomalgeneanalysisforbreastcancerprognosisusingmachinelearning
AT jinghuipeng integratingmitochondrialandlysosomalgeneanalysisforbreastcancerprognosisusingmachinelearning